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to undergo anatomic correction. Among the later modi-
fications of the Fontan operation, a significant alteration
was introduced by de Leval and associates2 when they
described total cavopulmonary connection (TCPC).
This technique offers many advantages that theoretical-
ly reduce the risk of early and long-term complications
caused by an enlarged right atrium.3
Natriuretic peptide is a peptide with cyclically formed
amino acid residues and has several biologic effects:
natriuresis and diuresis, vasodilation, suppression of
renin, and aldosterone secretion.4 Atrial natriuretic pep-
tide (ANP) is secreted mainly from atrial muscle, with
the major stimulus being atrial stretch, and brain natri-
uretic peptide (BNP) is secreted from the ventricular
muscles.5,6 Although studies have established that
abrupt increases in right atrial pressure result in the ele-
S ince Fontan and Baudet1 first described their tech-nique for correcting tricuspid atresia in 1971, the
original or modified Fontan operation has been widely
used to correct various heart defects in patients not able
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Objectives: Among the modifications of the Fontan operation currently
being used, total cavopulmonary connection offers the greatest potential for
optimizing early and long-term postoperative outcomes. Although studies
have established that abrupt increases in right atrial pressure elevate the
plasma atrial natriuretic peptide level after the Fontan procedure, changes in
plasma natriuretic peptide levels after total cavopulmonary connection have
not been clarified. Our hypothesis is that secretion of atrial natriuretic pep-
tide may be suppressed in patients undergoing total cavopulmonary connec-
tion because the atrium continues to function at low pressure in those
patients. In this study, we measured plasma levels of atrial and brain natri-
uretic peptide before and during the postoperative period in patients under-
going total cavopulmonary connection.
Methods: We evaluated 60 patients: 30 patients underwent total cavopul-
monary connection and 30 patients underwent definitive repair for Fallot’s
tetralogy. Blood samples for measurement of atrial and brain natriuretic pep-
tide were obtained before the operation and in the postoperative period.
Results: Plasma levels of atrial and brain natriuretic peptide were signifi-
cantly lower during the early postoperative period in patients undergoing
total cavopulmonary connection than in patients undergoing definitive repair
for Fallot’s tetralogy. No correlations were identified between the atrial natri-
uretic peptide levels and central venous pressure after total cavopulmonary
connection.
Conclusion: These results suggest that total cavopulmonary connection atten-
uates the secretion of atrial and brain natriuretic peptide in the early postop-
erative period. The suppressed release of atrial and brain natriuretic peptide
after total cavopulmonary connection may have clinical importance. (J
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vation of the plasma ANP level after the Fontan proce-
dure,7-9 changes in plasma natriuretic peptide levels
after TCPC have not been clarified. Our hypothesis is
that ANP secretion may be suppressed in patients
undergoing TCPC because the atrium continues to
function at a low pressure in those patients. Therefore,
to determine whether the TCPC attenuates natriuretic
peptide secretion in the early postoperative period, we
measured plasma levels of ANP and BNP before the
operation and during the postoperative period in
patients who underwent TCPC.
Patients and methods
Study population. Thirty patients undergoing TCPC were
studied. Mean age at operation was 7.1 ± 3.2 years, ranging
from 1 to 18 years, and mean body weight was 19.6 ± 7.2 kg,
ranging from 10.6 to 47.5 kg. Diagnoses included univentric-
ular heart (n = 14), tricuspid atresia (n = 5), double-outlet
right ventricle (n = 5), mitral atresia (n = 3), pulmonary atre-
sia with intact ventricular septum (n = 2), and pulmonary
atresia with ventricular septal defect (n = 1). All patients had
previously undergone cardiac surgery: 30 Blalock-Taussig
shunts in 20 patients, pulmonary artery banding in 8, a Glenn
shunt in 3, subclavian flap aortoplasty in 3, atrial septectomy
Fig 1. Plots show central venous pressure (A) and left atrial pressure (B) during the study protocol in patients
undergoing TCPC (solid line) and in patients undergoing definitive repair for tetralogy of Fallot (T/F).
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in 2, release of pulmonary venous obstruction in 2, pul-
monary valvotomy in 1, and right atrial–right ventricular
anastomosis in 1. An extracardiac TCPC was performed in 20
patients, and intra-atrial conduit TCPC was performed in 10
others. A 16- to 22-mm expanded polytetrafluoroethylene
tube graft was interposed between the inferior vena cava and
pulmonary artery in all but 1 patient, who underwent extra-
cardiac TCPC with direct anastomosis between the pul-
monary trunk and the inferior vena cava. If necessary, the
atrial septal defect was enlarged so as not to disturb the pul-
monary venous return. Unless a concomitant intracardiac
procedure was to be performed, aortic crossclamping was
avoided. Every effort was made to minimize the duration of
cardiopulmonary bypass (CPB). Two patients underwent the
entire operation without CPB.
For comparison with the TCPC group, 30 patients who
were undergoing definitive repair for Fallot’s tetralogy were
studied. Their mean age at operation was 5.9 ± 2.5 years,
ranging from 1 to 13 years, and mean body weight was 17.8
± 5.5 kg, ranging from 10.5 to 38.8 kg. Fourteen patients had
previously undergone a Blalock-Taussig shunt operation.
In all patients, an arterial line for continuous blood pressure
monitoring and blood sampling and a central venous line for
central venous pressure monitoring were placed.
Additionally, a 2F catheter was inserted into the left atrium
for pressure tracings. If necessary, dopamine (3-15 µg · kg–1
· min–1), dobutamine (3 to 10 µg · kg–1 · min–1)), or epineph-
rine (0.025 to 0.2 µg · kg–1 · min–1) was used as an inotropic
agent. Informed consent was obtained from each participat-
ing patient.
Study protocol and measurements of natriuretic pep-
tides. Plasma ANP and BNP concentrations and hemody-
namic parameters were measured at 8 points during the study
protocol as follows: (1) after induction of anesthesia and
before skin incision, (2) during CPB (except in the 2 patients
who underwent TCPC without CPB), (3) immediately after
discontinuation of CPB (or immediately after establishment
of the Fontan circulation in the 2 patients without CPB), (4)
3 hours after CPB, (5) 6 hours after CPB, (6) on the first post-
operative day, (7) on the third postoperative day, and (8) on
the seventh postoperative day. Blood samples were collected
via a radial arterial line during the first 3 days after the oper-
ation and were obtained by venipuncture on the seventh post-
operative day. Each blood specimen was collected in a chilled
tube containing 4.5 mg of sodium ethylenediaminetetraacetic
acid and 1500 units of aprotinin. The blood sample was cen-
trifuged immediately, and the plasma was frozen and stored
until hormone assay was performed. Concentrations of plas-
ma ANP and BNP were measured by a commercially avail-
able specific radioimmunoassay system (SRL, Tokyo, Japan).
The concentrations of ANP and BNP were expressed in
picograms per milliliter, and their normal ranges were less
than 40 pg/mL and 20 pg/mL, respectively.
Statistical analysis. All values are expressed as mean ±
standard deviation. The differences from control patients
were determined by factorial analysis of variance. When a
significant difference was detected, the Scheffé multiple
range test was applied.
Results
Operative mortality and morbidity. Two early
deaths occurred in the TCPC group. The first patient
died of low cardiac output syndrome caused by pul-
monary artery thrombosis. The second death was in a
patient with a severely unbalanced pulmonary artery.
This patient died of ventricular tachyarrhythmia on
postoperative day 3. Inhaled nitric oxide was adminis-
tered to 17 patients with critical pulmonary perfusion.
Six patients required thoracocentesis for persistence of
pleural or pericardial effusions for more than 2 weeks.
No perioperative deaths or critical complications
occurred in the group with tetralogy of Fallot.
Hemodynamic parameters. No differences were
detected in heart rate and blood pressure between the 2
groups during the study protocol. Before the operation,
central venous pressure in patients who underwent
Fig 2. Plasma ANP levels during the study protocol.
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TCPC was slightly higher than that in patients who
underwent definitive repair for Fallot’s tetralogy.
Central venous pressure increased in the TCPC group
soon after establishment of the Fontan circulation and
remained at the same levels thereafter. No significant
change in central venous pressure was noted in patients
with Fallot’s tetralogy during the perioperative course.
Central venous pressure differed significantly between
the 2 groups at every postoperative point (Fig 1, A), and
mean left atrial pressure was lower for the TCPC group
than for the tetralogy of Fallot group at every postoper-
ative interval (Fig 1, B).
Plasma ANP and BNP concentrations. Time cours-
es of plasma ANP and BNP levels during the study pro-
tocol are shown in Figs 2 and 3, respectively. The plas-
ma ANP level before the operation was significantly
higher in the TCPC group than in the tetralogy of Fallot
group. ANP concentration increased 3-fold in the
Fallot’s tetralogy group 3 days after the operation.
Plasma ANP levels were significantly lower at 1, 3, and
7 days after the operation in the TCPC group than in the
tetralogy of Fallot group (Fig 2). Plasma BNP levels
before the operation were significantly higher in the
TCPC group than in the group with tetralogy of Fallot.
The plasma BNP levels increased abruptly after the
operation in patients with Fallot’s tetralogy, as well as
in patients who underwent TCPC, but were significant-
ly lower in patients who underwent TCPC (Fig 3).
Perioperative ANP and BNP levels in 2 patients who
underwent TCPC without CPB were not different from
those in the patients who underwent TCPC with CPB.
Discussion
The heart functions not only as a pump, but also as an
important endocrine organ that secretes 2 natriuretic
peptides.4 One is ANP, primarily derived from the atri-
um with the major stimuli being atrial stretch and ele-
vation of intra-atrial pressure. The other is BNP, which
is synthesized and secreted by the ventricles. ANP has
multiple biologic actions including natriuresis, diure-
sis, vasodilation of the systemic and pulmonary arter-
ies, and inhibition of the secretion of aldosterone. BNP
plays an important role in regulating somatic fluid and
blood pressure.5,6 The plasma concentrations of ANP
and BNP are markedly elevated in patients with con-
gestive heart failure in proportion to the severity of the
disease.5 Although many reports have examined plas-
ma ANP and BNP concentrations in chronic heart fail-
ure,5,6 few have explored the changes in plasma natri-
uretic peptide concentrations during and after various
cardiac operations.10-13 Moreover, the period during
and after corrective operations for congenital heart dis-
ease in children is characterized by a complex patho-
physiologic condition with diminished performance of
the myocardium, increased capillary permeability, and
disturbed volume homeostasis.14-17 Only very limited
data exist regarding the role of the natriuretic peptide
family in such patients. Pfenninger and associates,15
who studied 22 children with various types of congen-
ital heart disease, concluded that plasma ANP concen-
trations are increased after cardiac surgery in children
and that this increase is moderately correlated with the
blood volume status of the patient. Stewart and associ-
ates7,8 measured plasma levels of ANP in children
undergoing the Fontan operation (atriopulmonary anas-
tomosis) and concluded that the Fontan anastomosis
resulted in a drastic increase in plasma ANP levels
because of right atrial stretch. Hiramatsu and associ-
ates9 also reported that abrupt increases in right atrial
pressure after the Fontan operation had been associated
Fig 3. Plasma BNP levels during the study protocol.
with extreme elevations in plasma levels of ANP, with
a positive, statistically significant correlation between
central venous pressure and plasma ANP levels.
Our study reveals 3 main findings. First, plasma ANP
levels were significantly lower during the early postop-
erative period in the TCPC group than in the group with
tetralogy of Fallot. Second, no correlation was identi-
fied between the ANP levels and central venous pres-
sure after TCPC, suggesting that the secretion of ANP
was suppressed in patients undergoing TCPC. Third,
postoperative plasma BNP concentrations changed to a
lesser degree in patients who underwent TCPC com-
pared with those in patients with Fallot’s tetralogy.
We hypothesized that TCPC with an extracardiac or
intra-atrial conduit attenuates ANP secretion because
all parts of the atrium continue to function at a low
pressure in those patients. Although the central venous
pressure increased after establishment of the Fontan
circulation, there was no concomitant increase in atrial
pressure or atrial distention in patients who underwent
extracardiac or intra-atrial conduit TCPC. Burch and
associates18 measured plasma ANP levels in 3 children
undergoing TCPC and reported that the ability to
release ANP into the circulation was impaired after
TCPC compared with that after the Fontan procedure.
They also stated that the impaired release of ANP
might result in retention of salt and water after TCPC.
Recently, human ANP has been produced commercial-
ly by a genetic recombinant technique (Suntory; Osaka,
Japan). Hiramatsu and associates9 examined the effects
of human ANP on hemodynamic parameters after the
Fontan procedure and concluded that human ANP
could be a physiologic diuretic and a pulmonary
vasodilator after this procedure. The administration of
human ANP should offer the possibility of combining
the hemodynamic benefits of TCPC with the endocrine
benefits of the Fontan procedure.
Although previous studies have shown changes in
plasma ANP concentrations associated with cardiac
surgery,7-18 the effects of cardiac surgery with CPB on
plasma BNP concentrations have not yet been clarified.
Morimoto and associates19 examined plasma concen-
trations of BNP during the perioperative period in adult
patients undergoing cardiac surgery. They concluded
that the plasma BNP concentrations became markedly
and abruptly elevated after CPB and reflected the state
of left ventricular function. Ationu and associates20 had
measured plasma BNP concentrations in 9 children
undergoing cardiac surgery with CPB and concluded
that the major source of plasma BNP in patients with
congenital heart defects is the cardiac ventricle. In the
present study, plasma BNP levels increased abruptly
after cessation of CPB in patients with Fallot’s tetralo-
gy, as well as in patients undergoing TCPC. This result
was in accord with that of Morimoto and associates.19
However, plasma BNP concentrations were significant-
ly lower in the TCPC group than in the group with
Fallot’s tetralogy. BNP is secreted mainly from the left
ventricle and its secretion increases in proportion to the
severity of the ventricular dysfunction.6 Ikeda and col-
leagues21 reported that secretion of BNP is stimulated
by the increase of left ventricular end-systolic wall
stress in patients with aortic stenosis. Hayabuchi,
Matsuoka, and Kuroda22 studied 14 patients with sur-
gically repaired Fallot’s tetralogy and concluded that
the BNP concentration reflects right ventricular pres-
sure and volume overload. We are uncertain why plas-
ma BNP levels were lower in patients undergoing
TCPC than those in patients with Fallot’s tetralogy. The
probable reason is that the TCPC procedure offers the
considerable advantage of lowering the ventricular vol-
ume load in the immediate postoperative period,23
which would result in the suppression of BNP secre-
tion, whereas the volume overload of both ventricles
increases immediately after repair for Fallot’s tetralo-
gy.24 The suddenly increased loading in both ventricles
may be partly compensated for by the increase of BNP
secretion.
Limitation of the present study. The limitation of
the present study was that underlying heart conditions
differed between the 2 groups. The group with Fallot’s
tetralogy was used as a control group to compare the
postoperative changes in plasma ANP and BNP con-
centrations. Taking into consideration the multiple fac-
tors that may affect ANP and BNP levels, a group of
patients who underwent the original or modified
Fontan operation (atriopulmonary anastomosis) would
have been more suitable as a control group, but such a
group would have been extremely difficult to incorpo-
rate into the study, because we currently use TCPC as
the procedure of choice.3
The patients in the TCPC group had higher plasma
levels of ANP and BNP than the Fallot’s tetralogy
group before the operation. The probable reason is the
wide spectrum of underlying heart disease and its
severity in patients who underwent TCPC. Several
patients in the TCPC group had high ANP and BNP
levels before the operation; these patients might have
been in more serious condition than the patients with
Fallot’s tetralogy. Nevertheless, after the operation
those levels became lower in the TCPC group. Stewart
and associates7,8 reported that plasma ANP levels
increased in excess of 300 pg/mL after establishment
of atriopulmonary anastomosis in patients undergoing
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the Fontan procedure. On the other hand, plasma ANP
levels remained in the range between 50 and 100
pg/mL in our series of patients having TCPC. These
results suggested that the ability to release ANP and
BNP into the circulation is suppressed after TCPC.
Conclusion
We measured plasma levels of ANP and BNP before
the operation and during the postoperative period in
patients who were undergoing TCPC. These results
were compared with those in patients with Fallot’s
tetralogy. Plasma ANP levels were significantly lower
during the early postoperative period in the TCPC
group than in the Fallot’s tetralogy group, and there
was no correlation between the ANP levels and central
venous pressure after TCPC. Postoperative plasma
BNP concentrations also changed to lower levels in
patients who underwent TCPC than in those with
Fallot’s tetralogy. Despite several limitations of our
study as a clinical approach, we have demonstrated
that TCPC attenuates ANP and BNP secretion in the
early postoperative period. The suppressed release of
ANP and BNP after TCPC may have clinical impor-
tance.
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